Weight & Metabolism
Semaglutide
Choose an option
Select the amount per vial, then choose a package size.
Amount per vial
Package size
Your estimate includes a flat $65 shipping charge and an 8% transaction fee on the product subtotal. No payment is collected here.
Overview
Standard-dose GLP-1 receptor agonist for metabolic research. FDA-approved compound (Ozempic/Wegovy) studied for type 2 diabetes, obesity, and cardiovascular risk reduction.
- Selected variation
- Semaglutide 10mg
- Amount per vial
- 10mg
- Intended use
- Laboratory research only
- Route of administration
- Subcutaneous injection
Research information
Semaglutide is a GLP-1 receptor agonist that mimics the action of incretin hormones to regulate blood glucose and appetite. It is extensively studied for its metabolic effects and weight management potential. While widely researched, its use is strictly limited to controlled laboratory and clinical environments.
For laboratory research only. Not for human or animal consumption. Catalog information is not medical advice or a claim of therapeutic benefit.